🇺🇸 FDA
Patent

US 12370196

Pharmaceutical compositions comprising meloxicam

granted A61KA61K31/4196A61K31/5415

Quick answer

US patent 12370196 (Pharmaceutical compositions comprising meloxicam) held by AXSOME THERAPEUTICS, INC. expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AXSOME THERAPEUTICS, INC.
Grant date
Tue Jul 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/4196, A61K31/5415, A61P, A61P25/06